Jun Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jun Jiang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Fan Li
Endoscopy Center, Minhang Hospital, Fudan University, Shanghai, China
2 shared publications- Li Feng
Endoscopy Center, Minhang Hospital, Fudan University, Shanghai, China
2 shared publications Xiaohong Zhang
Endoscopy Center, Minhang Hospital, Fudan University, Shanghai, China
2 shared publicationsFangzhou Ye
Endoscopy Center, Minhang Hospital, Fudan University, Shanghai, China
1 shared publicationHao Gu
Endoscopy Center, Minhang District Central Hospital, Fudan University, Shanghai, China
1 shared publicationHuanqing Li
Endoscopy Center, Minhang Hospital, Fudan University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 28 January 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
RHOJ derived peptide promotes chemosensitivity by inhibiting glutamine metabolism in gastric cancer
Chemoresistance is a cause of chemotherapy failure in gastric cancer (GC) treatment. Recent studies have shown that the dysregulation of glutamine metaboli
- 28 January 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessRHOJ derived peptide promotes chemosensitivity by inhibiting glutamine metabolism in gastric cancer
Chemoresistance is a cause of chemotherapy failure in gastric cancer (GC) treatment. Recent studies have shown that the dysregulation of glutamine metaboli
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (8) , 6151-6162
Alleviation of exercise-induced injury by hydrogen inhalation via the reduction of oxidative stress and inflammation in athletes
Background: Strenuous exercise can lead to exercise-induced lung injury, primarily driven by elevated oxidative stress and systemic inflammation. Although hydrogen (H2) inhalation has been proposed as a nonpharmacological intervention with antioxidant and anti-inflammatory potential, its effects in the context of exercise remain poorly understood. This study aimed to investigate whether H2 inhalation could mitigate exercise-induced systemic stress responses in athletes. Methods: Thirty-one healthy athletes were divided into a control group (n=14), an infrared blanket group (n=9), and a H2 inhalation group (n=8). Blood samples were collected before and after winter training to evaluate oxidative stress [total antioxidant capacity (T-AOC), superoxide dismutase (SOD), and malondialdehyde (MDA)], inflammation and lung injury-related markers [white blood cell count (WBC)], C-reactive protein (CRP), hematological indicators [red blood cell count (RBC), hemoglobin (HB), hematocrit (HCT), and mean corpuscular volume (MCV)], biochemical indicators [creatine kinase (CK) and blood urea nitrogen (BUN)], and stress-related hormones [total cholesterol (T), cholesterol (C), and ferritin (FE)]. Lung injury was considered to reflect exercise-induced lung stress. The systemic and inflammatory indices of stimulation were inferred. Results: After a single postexercise intervention, the H2 group showed improved antioxidant capacity and reduced WBC and CRP levels. These effects persisted after winter training. Moreover, the H2 group maintained stable RBC, HB, and HCT levels, unlike the infrared blanket group, suggesting better preservation of oxygen-carrying capacity and hematological stability. Conclusions: H2 inhalation attenuates exercise-induced lung injury by reducing oxidative stress and inflammation. It may represent a promising adjunctive approach for protecting pulmonary function during intensive athletic training in the winter.
- 1 August 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (8) , 6151-6162
Open AccessAlleviation of exercise-induced injury by hydrogen inhalation via the reduction of oxidative stress and inflammation in athletes
Background: Strenuous exercise can lead to exercise-induced lung injury, primarily driven by elevated oxidative stress and systemic inflammation. Although hydrogen (H2) inhalation has been proposed as a nonpharmacological intervention with antioxidant and anti-inflammatory potential, its effects in the context of exercise remain poorly understood. This study aimed to investigate whether H2 inhalation could mitigate exercise-induced systemic stress responses in athletes. Methods: Thirty-one healthy athletes were divided into a control group (n=14), an infrared blanket group (n=9), and a H2 inhalation group (n=8). Blood samples were collected before and after winter training to evaluate oxidative stress [total antioxidant capacity (T-AOC), superoxide dismutase (SOD), and malondialdehyde (MDA)], inflammation and lung injury-related markers [white blood cell count (WBC)], C-reactive protein (CRP), hematological indicators [red blood cell count (RBC), hemoglobin (HB), hematocrit (HCT), and mean corpuscular volume (MCV)], biochemical indicators [creatine kinase (CK) and blood urea nitrogen (BUN)], and stress-related hormones [total cholesterol (T), cholesterol (C), and ferritin (FE)]. Lung injury was considered to reflect exercise-induced lung stress. The systemic and inflammatory indices of stimulation were inferred. Results: After a single postexercise intervention, the H2 group showed improved antioxidant capacity and reduced WBC and CRP levels. These effects persisted after winter training. Moreover, the H2 group maintained stable RBC, HB, and HCT levels, unlike the infrared blanket group, suggesting better preservation of oxygen-carrying capacity and hematological stability. Conclusions: H2 inhalation attenuates exercise-induced lung injury by reducing oxidative stress and inflammation. It may represent a promising adjunctive approach for protecting pulmonary function during intensive athletic training in the winter.
- 4 March 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
RXRA induces endoplasmic reticulum stress via ATP2A3 transcriptional modulation in ovarian cancer cells
Introduction: Ovarian cancer (OV) progression involves intricate interactions of genes and cellular pathways, with the ATP2A gene family recently emerging as significant.Material and methods: Through bioinformatic analysis, we evaluated the expression and prognostic impact of the ATP2A gene family in various cancers, emphasizing OV. Immunohistochemical and clinical expression profiles of ATP2A2 were subsequently analyzed in OVs. We further explored the effects of ATP2A3 modulation on cellular behaviors, involving proliferation, apoptosis, migration, and invasion in OV cell lines. The function of ATP2A3 in mediating endoplasmic reticulum (ER) stress and its influence on calcium-mediated kinase activities was elucidated. Furthermore, a comprehensive analysis of The Cancer Genome Atlas (TCGA) was conducted, spotlighting the interplay between RXRA and ATP2A3. Finally, their effects on OV cell progression were analyzed in vitro.Results: Our results highlighted a consistent association between low expression of ATP2A3 in OV and improved patient prognosis. ATP2A3 regulation has significant effects on the proliferation, apoptosis, migration, and invasion of OV cells. Notably, overexpression of ATP2A3 enhanced ER stress biomarkers but inhibited calcium-mediated kinase activity. At the same time, in vitro cell experiments found that RXRA overexpression can inhibit the malignant behavior of OV cells, and it is positively correlated with ATP2A3. Overexpression of RXRA inhibited OV progression by inducing the ER stress response, which was partially offset by ATP2A3.Conclusions: ATP2A3 and RXRA synergistically modulate OV cell behaviors and the ER stress response, revealing prospective therapeutic avenues for OV intervention.
- 4 March 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
RXRA induces endoplasmic reticulum stress via ATP2A3 transcriptional modulation in ovarian cancer cells
Introduction: Ovarian cancer (OV) progression involves intricate interactions of genes and cellular pathways, with the ATP2A gene family recently emerging as significant.Material and methods: Through bioinformatic analysis, we evaluated the expression and prognostic impact of the ATP2A gene family in various cancers, emphasizing OV. Immunohistochemical and clinical expression profiles of ATP2A2 were subsequently analyzed in OVs. We further explored the effects of ATP2A3 modulation on cellular behaviors, involving proliferation, apoptosis, migration, and invasion in OV cell lines. The function of ATP2A3 in mediating endoplasmic reticulum (ER) stress and its influence on calcium-mediated kinase activities was elucidated. Furthermore, a comprehensive analysis of The Cancer Genome Atlas (TCGA) was conducted, spotlighting the interplay between RXRA and ATP2A3. Finally, their effects on OV cell progression were analyzed in vitro.Results: Our results highlighted a consistent association between low expression of ATP2A3 in OV and improved patient prognosis. ATP2A3 regulation has significant effects on the proliferation, apoptosis, migration, and invasion of OV cells. Notably, overexpression of ATP2A3 enhanced ER stress biomarkers but inhibited calcium-mediated kinase activity. At the same time, in vitro cell experiments found that RXRA overexpression can inhibit the malignant behavior of OV cells, and it is positively correlated with ATP2A3. Overexpression of RXRA inhibited OV progression by inducing the ER stress response, which was partially offset by ATP2A3.Conclusions: ATP2A3 and RXRA synergistically modulate OV cell behaviors and the ER stress response, revealing prospective therapeutic avenues for OV intervention.